[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 266
Citations 0
Lab Reports
October 3, 2012

Potential Target for ALS Therapy

JAMA. 2012;308(13):1310. doi:10.1001/jama.2012.13154

Expression of EPHA4, a receptor previously shown to influence axon growth, was inversely correlated with late disease onset and survival in 158 Dutch patients with amyotrophic lateral sclerosis (ALS), report investigators from Belgium (Van Hoecke A et al. Nat Med. doi:10.1038/nm.2901 [published online August 26, 2012]). EPHA4 binds to ephrins, proteins thought to play a role in synapse formation and regulation of long-term synaptic plasticity and memory.

First Page Preview View Large
First page PDF preview
First page PDF preview
×